tirzepatide health canada approval Zepbound approved in for obesity and sleep apnea treatment Health Canada approves first sleep

Fink-Jensen et al

However, compounded versions are not FDA-approved , may vary in quality, and aren't covered by the official savings card

For weight management under the Zepbound brand, qualification generally requires a body mass index of 30 or higher, or 27 or higher with at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol

Weight loss of just 5-10% has been shown to improve insulin sensitivity, reduce androgen levels, restore ovulatory cycles, and enhance fertility in women with PCOS

The way it works in the body is complex and seems to affect more than just appetite for food